Figure 1.

Ultrasound images at baseline and 24 wk after baricitinib treatment in rheumatoid arthritis. Representative figure for gray-scale and power Doppler ultrasound images of wrist joint in a patient with rheumatoid arthritis. (A) Gray-scale synovial hypertrophy and joint effusion with widening of joint space and Doppler synovitis was also noted at baseline. (B) Gray-scale synovial hypertrophy and joint effusion within joint space was decreased and power Doppler signal was disappeared after treatment with baricitinib 4 mg for 24 wk.